| 1 |
33397455 | Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML. | 2021 Jan 4 |
1 |
| 2 |
33898313 | IDH1/IDH2 Inhibition in Acute Myeloid Leukemia. | 2021 |
1 |
| 3 |
34313176 | Real-world assessment of isocitrate dehydrogenase inhibitor-associated differentiation syndrome. | 2021 Dec |
2 |
| 4 |
32306411 | Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. | 2020 Oct |
1 |
| 5 |
32393603 | Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis. | 2020 Aug 15 |
2 |
| 6 |
32882760 | All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells. | 2020 Sep |
1 |
| 7 |
32955829 | Enasidenib and ivosidenib in AML. | 2020 Oct |
1 |
| 8 |
30715623 | New Treatment Options for Acute Myeloid Leukemia in 2019. | 2019 Feb 4 |
1 |
| 9 |
30958073 | Emerging drug profile: Krebs cycle and cancer: IDH mutations and therapeutic implications. | 2019 Nov |
1 |
| 10 |
31165048 | Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics. | 2019 |
3 |
| 11 |
31660152 | Isocitrate dehydrogenase inhibitors in acute myeloid leukemia. | 2019 |
2 |
| 12 |
31768950 | Novel IDH1-Targeted Glioma Therapies. | 2019 Dec |
1 |
| 13 |
31808888 | Single-agent and combination biologics in acute myeloid leukemia. | 2019 Dec 6 |
1 |
| 14 |
29346478 | Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study. | 2018 Aug 1 |
1 |
| 15 |
29773061 | Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer. | 2018 |
2 |
| 16 |
30013764 | The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia. | 2018 Jul |
1 |
| 17 |
28665599 | Importance of R-CF3···O Tetrel Bonding Interactions in Biological Systems. | 2017 Jul 20 |
1 |